SHH · EQUITY · ENHANCED MARKET DYNAMICS

603590

Beijing Konruns Pharmaceutical Co.,Ltd.

CN · Healthcare · Biotechnology

Open Chart Terminal

EMD SCORE49/100

CURRENT COMPLETED-WEEK READ

Balanced

Constructive and cautious evidence are close enough to require confirmation. Conditions remain cautious, although the latest readings are improving.

Early repair20% directional agreement74/100 evidence quality6/6 sources available

Completed week: 2 Oct 2026
Latest close: CNY 32.11
Evidence: 156 weeks

This report uses 2 Oct 2026. The latest completed calendar week is 9 Oct 2026; newer evidence has not yet reached this listing.

Four-week EMD change+35.8 pts

signed chart scale −100 to +100

Four-week price+6.9%

completed closing prices

Current directional run32 weeks

on the same side of EMD zero

Recent consistency0/13

recent readings above zero

COMPLETED-WEEK OVERVIEW

Price and market conditions over time

3 supportive · 2 cautious

Enhanced Market Dynamics and the price cycle156 completed weeks · bars use the left EMD axis; price uses the right axis.

22 Sep 2023–2 Oct 2026

Constructive EMDCautious EMDCompleted-week priceUp-cycle confirmationDown-cycle confirmation

Confirmation markers describe price-zone departures within this saved history. Earlier markers can change as the history changes; they are not a record of signals available in real time.

Cycle position 49%Current EMD -2.14-week EMD change +35.8Full saved history price range CNY 19.78–63.44

View chart values · 156 observations

Week	Close · CNY	EMD −100 to +100	Score /100	Agreement %	Coverage %
2023-09-22	35.14	50.02	75	100	83
2023-09-29	35.75	57.34	79	100	83
2023-10-13	35.92	59.1	80	100	83
2023-10-20	35.26	47.42	74	67	100
2023-10-27	36.73	66.84	83	100	100
2023-11-03	37.88	63.0	81	100	100
2023-11-10	38.34	69.93	85	100	100
2023-11-17	38.18	72.15	86	100	100
2023-11-24	39.76	75.82	88	100	100
2023-12-01	39.85	69.87	85	100	100
2023-12-08	38.54	54.18	77	67	100
2023-12-15	37.93	49.57	75	67	100
2023-12-22	36.87	42.72	71	60	100
2023-12-29	36.90	51.71	76	100	100
2024-01-05	35.50	24.19	62	50	100
2024-01-12	33.79	8.02	54	20	100
2024-01-19	31.77	-12.48	44	33	100
2024-01-26	30.57	-21.08	39	60	100
2024-02-02	26.16	-39.9	30	67	100
2024-02-09	28.10	-18.26	41	33	100
2024-02-23	28.97	-26.83	37	33	100
2024-03-01	29.87	-36.64	32	67	100
2024-03-08	28.92	-31.32	34	60	100
2024-03-15	29.87	-29.52	35	50	100
2024-03-22	30.45	-25.74	37	50	100
2024-03-29	30.33	-29.26	35	60	100
2024-04-05	30.48	-28.12	36	50	100
2024-04-12	28.34	-45.92	27	67	100
2024-04-19	27.74	-34.59	33	33	100
2024-04-26	28.57	-30.37	35	33	100
2024-05-03	28.66	-36.14	32	60	100
2024-05-10	30.74	-12.82	44	20	100
2024-05-17	29.62	-18.64	41	20	100
2024-05-24	27.33	-35.45	32	67	100
2024-05-31	27.42	-30.01	35	60	100
2024-06-07	25.02	-44.45	28	67	100
2024-06-14	25.66	-35.57	32	33	100
2024-06-21	25.51	-41.83	29	60	100
2024-06-28	24.75	-46.88	27	67	100
2024-07-05	23.80	-52.92	24	100	100
2024-07-12	24.78	-37.47	31	60	100
2024-07-19	24.25	-50.13	25	100	100
2024-07-26	22.75	-56.33	22	100	100
2024-08-02	23.55	-37.33	31	60	100
2024-08-09	23.58	-47.71	26	67	100
2024-08-16	25.01	-21.02	39	20	100
2024-08-23	22.12	-54.08	23	67	100
2024-08-30	22.28	-47.7	26	67	100
2024-09-06	21.53	-49.17	25	67	100
2024-09-13	20.26	-51.39	24	67	100
2024-09-20	19.78	-48.04	26	67	100
2024-09-27	22.35	-25.95	37	20	100
2024-10-04	24.32	-16.83	42	0	100
2024-10-11	22.95	-30.67	35	33	100
2024-10-18	22.89	-15.25	42	20	100
2024-10-25	23.63	-10.25	45	33	100
2024-11-01	22.90	-25.95	37	33	100
2024-11-08	24.39	-4.53	48	33	100
2024-11-15	23.59	-18.19	41	20	100
2024-11-22	23.48	-13.45	43	0	100
2024-11-29	24.79	4.81	52	33	100
2024-12-06	26.27	17.82	59	67	100
2024-12-13	26.65	20.21	60	60	100
2024-12-20	24.90	8.63	54	20	100
2024-12-27	23.75	9.15	55	50	100
2025-01-03	21.94	-17.22	41	33	100
2025-01-10	21.66	-25.63	37	60	100
2025-01-17	22.40	-21.26	39	60	100
2025-01-24	23.17	-17.28	41	50	100
2025-01-31	23.57	-6.3	47	20	100
2025-02-07	23.15	-11.1	44	20	100
2025-02-14	23.44	-5.43	47	0	100
2025-02-21	23.62	-11.52	44	33	100
2025-02-28	22.85	-23.93	38	67	100
2025-03-07	23.07	-18.38	41	60	100
2025-03-14	23.31	-0.53	50	0	100
2025-03-21	23.34	-6.64	47	20	100
2025-03-28	23.71	8.25	54	60	100
2025-04-04	26.69	58.24	79	100	100
2025-04-11	27.20	71.51	86	100	100
2025-04-18	27.89	53.85	77	67	100
2025-04-25	27.99	48.91	74	67	100
2025-05-02	30.08	75.84	88	100	100
2025-05-09	29.32	69.45	85	100	100
2025-05-16	29.01	72.11	86	100	100
2025-05-23	30.53	76.13	88	100	100
2025-05-30	30.44	74.06	87	100	100
2025-06-06	30.70	62.02	81	67	100
2025-06-13	32.42	66.48	83	67	100
2025-06-20	29.58	52.54	76	67	100
2025-06-27	31.58	74.19	87	100	100
2025-07-04	34.50	82.74	91	100	100
2025-07-11	43.91	90.68	95	100	100
2025-07-18	54.75	93.39	97	100	100
2025-07-25	57.59	67.62	84	67	100
2025-08-01	63.44	84.45	92	100	100
2025-08-08	56.29	59.61	80	67	100
2025-08-15	56.89	77.34	89	100	100
2025-08-22	52.85	55.56	78	67	100
2025-08-29	56.17	71.75	86	100	100
2025-09-05	56.93	59.78	80	67	100
2025-09-12	54.93	66.22	83	100	100
2025-09-19	56.35	60.96	80	67	100
2025-09-26	52.57	51.71	76	67	100
2025-10-03	53.80	57.46	79	100	100
2025-10-10	50.58	49.18	75	100	100
2025-10-17	49.22	30.04	65	20	100
2025-10-24	48.41	25.2	63	0	100
2025-10-31	50.50	33.11	67	33	100
2025-11-07	45.80	16.75	58	0	100
2025-11-14	47.42	29.17	65	50	100
2025-11-21	42.76	5.46	53	20	100
2025-11-28	44.68	2.63	51	20	100
2025-12-05	42.79	-12.02	44	33	100
2025-12-12	43.03	-8.69	46	20	100
2025-12-19	41.68	-14.3	43	20	100
2025-12-26	40.00	-31.74	34	67	100
2026-01-02	39.75	-32.71	34	67	100
2026-01-09	45.04	0.59	50	20	100
2026-01-16	42.63	-27.04	36	60	100
2026-01-23	42.93	-19.63	40	33	100
2026-01-30	40.33	-31.89	34	67	100
2026-02-06	43.01	-15.68	42	33	100
2026-02-13	42.15	-31.81	34	67	100
2026-02-27	42.92	-18.9	41	20	100
2026-03-06	40.89	-28.26	36	50	100
2026-03-13	38.09	-44.33	28	67	100
2026-03-20	36.42	-45.7	27	67	100
2026-03-27	36.76	-32.42	34	33	100
2026-04-03	37.74	-38.33	31	60	100
2026-04-10	37.72	-33.28	33	50	100
2026-04-17	38.61	-30.21	35	50	100
2026-04-24	35.25	-47.57	26	67	100
2026-05-01	35.40	-46.89	27	67	100
2026-05-08	35.62	-40.18	30	60	100
2026-05-15	35.09	-52.28	24	67	100
2026-05-22	37.76	-24.19	38	20	100
2026-05-29	34.45	-51.06	24	67	100
2026-06-05	30.11	-47.12	26	60	100
2026-06-12	29.60	-46.14	27	60	100
2026-06-19	29.15	-47.38	26	60	100
2026-06-26	27.82	-49.61	25	60	100
2026-07-03	31.37	-38.14	31	50	100
2026-07-10	31.93	-36.66	32	50	100
2026-07-17	34.21	-32.95	34	33	100
2026-07-24	31.57	-30.99	35	33	100
2026-07-31	29.76	-41.51	29	67	100
2026-08-07	32.94	-18.36	41	20	100
2026-08-14	32.73	-31.62	34	60	100
2026-08-21	32.21	-40.47	30	50	100
2026-08-28	30.75	-29.57	35	50	100
2026-09-04	30.03	-37.92	31	60	100
2026-09-11	28.41	-38.98	31	60	100
2026-09-18	28.80	-28.4	36	50	100
2026-09-25	29.38	-27.52	36	50	100
2026-10-02	32.11	-2.13	49	20	100

SIX SOURCES · LAST 26 OBSERVATIONS

Is support broadening or thinning?

Green is supportive, rose is cautious.
Grey means the reading is unavailable.

Reading	10 Apr	17 Apr	24 Apr	1 May	8 May	15 May	22 May	29 May	5 Jun	12 Jun	19 Jun	26 Jun	3 Jul	10 Jul	17 Jul	24 Jul	31 Jul	7 Aug	14 Aug	21 Aug	28 Aug	4 Sep	11 Sep	18 Sep	25 Sep	2 Oct
Trend	2	3	1	1	1	1	8	1	0	0	0	0	1	2	8	2	1	6	7	6	3	2	1	2	3	21
Momentum	45	50	33	29	33	26	53	33	20	21	21	20	46	51	59	58	32	50	39	45	49	39	33	37	48	64
Underlying pressure	21	24	22	17	14	11	15	17	16	13	9	7	9	11	17	24	28	38	41	48	51	52	51	48	51	55
Price & volume	53	53	27	37	56	28	67	18	45	51	52	47	53	50	33	43	44	75	47	0	35	20	25	56	42	81
Relative strength	6	7	2	2	2	1	4	1	0	0	0	0	1	1	5	2	1	3	3	4	2	2	1	2	3	11
Modeled Trend	57	58	59	59	59	59	60	60	59	58	58	58	57	57	57	57	57	56	56	57	57	58	58	57	57	59

Each cell is a finished component score from 0–100. Components can disagree even when the combined reading stays positive.

STRONGEST CURRENT SOURCE

Price & volume

81/100

LEAST SUPPORTIVE SOURCE

Relative strength

11/100

WHAT WOULD CHANGE THE READ?

Three paths to keep in view

Conditional research scenarios.
No assumed price target or timing.

Continuation

Price and evidence stay together

Further price weakness alongside cautious trend, pressure and relative strength would support the current defensive read.

Change of direction

Repair needs follow-through

Improving EMD while price still falls is an early observation. A turn in price and broader agreement would strengthen a repair case.

Cycle context

A range extreme is a location

An upper zone can persist during a strong advance; a lower zone can persist during a decline. Use departures, EMD direction and the related price charts together.

EARLIER COMPARABLE READINGS

What followed similar conditions?

Same ticker · similar score and direction of change.
Returns exclude costs and dividends.

4 WEEKS LATER-5.8%

Median price return · 7 non-overlapping examples

Observed range: -19.0% to +16.7%
Positive returns: 29%
All-period comparison: -3.2% median

13 WEEKS LATER-5.7%

Median price return · 3 non-overlapping examples

Observed range: -23.3% to +27.6%
Positive returns: 33%
All-period comparison: -10.7% median

How these comparisons are selected

Earlier observations must have the same constructive/fading/repair/deterioration condition, a score within ten points of today’s score and at least the same component coverage. The first 30 observations are omitted for warm-up; examples are spaced by the forward horizon to avoid overlap. Gapped return windows are excluded. The all-period comparison uses the same available history and spacing, without matching the current state. These are reconstructed observations, not a point-in-time strategy backtest or a forecast.

RECENT CYCLE HISTORY

How the current reading developed

26 Dec 2025Down-cycle confirmedCNY 40.00

4 Jul 2025Upper cycle zone confirmedCNY 34.50

28 Mar 2025Up-cycle confirmedCNY 23.71

31 Jan 2025Up-cycle confirmedCNY 23.57

8 Nov 2024Up-cycle confirmedCNY 24.39

4 Oct 2024Up-cycle confirmedCNY 24.32

10 May 2024Up-cycle confirmedCNY 30.74

12 Apr 2024Lower cycle zone confirmedCNY 28.34

THE FULL PRICE CYCLE

Follow the journey from one zone to the other

Cycle states use trailing completed-week observations.

Lower zone

Price establishes residence near the bottom of its long-cycle range. Improving EMD separates early repair from continued deterioration.

Upward journey

Price leaves the lower zone while EMD confirms improving participation. The objective is the broader move toward the upper zone, not a short weekly trade.

Upper zone

Price establishes residence near the top of its long-cycle range. A high range position can persist. Watch EMD for exhaustion and loss of support before interpreting it as a turn.

Downward journey

Price leaves the upper zone while EMD weakens. The reverse cycle remains active until lower-zone residence is confirmed again.

CURRENT READINGS